跳至主要内容
临床试验/JPRN-UMIN000006432
JPRN-UMIN000006432招募中未知

Early treatment of glucose toxicity with sitagliptin prevent progression of arteriosclerosis in cardiovascular disease patients - SPARC study

Cardiovascular Center,Anjo Kosei Hospital0 个研究点目标入组 100 人开始时间: 2011年9月29日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Any subject who applies to the article below shall be excluded. 1) Patients on oral antidiabetic or insulin preparation 2) Patients with a history of ileus or undergone laparotomy 3) Patients with severe liver dysfunction or renal dysfunction 4) Patients with serious case of ketosis or diabetical coma, or precoma 5) Patients with severe infection disease, or in the perioperative period, or with extreme trauma 6)Patient who caused myocardial infarction within the past six months 7) Patients with a history of sensitivity to Sitagliptin 8) Pregnant or possibly pregnant women 9) Patients judged by the investigator/subinvestigator to be ineligible for some other reason

研究者

发起方
Cardiovascular Center,Anjo Kosei Hospital

相似试验